Taysha Gene Therapies shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $415k | 127k | 3.27 |
| 2025-06-30 | $250k | 108k | 2.31 |
| 2025-03-31 | $150k | 108k | 1.39 |
| 2024-12-31 | $109k | 63k | 1.73 |
| 2024-09-30 | $153k | 76k | 2.01 |
| 2024-06-30 | $94k | 42k | 2.24 |
| 2021-12-31 | $111k | 9.5k | 11.65 |
| 2021-09-30 | $177k | 9.5k | 18.62 |
| 2021-06-30 | $202k | 9.5k | 21.24 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors